title: Recommendations of the Fertility Task Force of the European Society of Gynecologic Oncology about the conservative management of ovarian malignant tumors.
abstract: In young patients with borderline ovarian tumor a conservative treatment approach does not seem to have a significant impact on survival, and the outcome regarding fertility is good in general. It can be considered even if noninvasive peritoneal implants are discovered at the time of the initial surgery. In contrast, in patients with epithelial ovarian cancer, conservative surgery should be considered only in adequately staged patients, with a stage IA grade 1 (and probably 2) serous, mucinous or an endometrioid tumor, including a careful follow-up. Such an approach could also probably be discussed in stage IC grade 1 disease.In patients with nonepithelial malignant ovarian tumors, conservative surgery is also feasible, particularly in patients with malignant germ cell tumors because of their high chemosensitivity leading to an excellent prognosis in general.
authors.affiliation: ESGO Task Force for Fertility Preservation in Gynecological Cancer, Geneva, Switzerland. morice@igr.fr
authors.forename: Philippe
authors.initials: P
authors.lastname: Morice
authors.forename: Dominik
authors.initials: D
authors.lastname: Denschlag
authors.forename: Alex
authors.initials: A
authors.lastname: Rodolakis
authors.forename: Nick
authors.initials: N
authors.lastname: Reed
authors.forename: Achim
authors.initials: A
authors.lastname: Schneider
authors.forename: Vesna
authors.initials: V
authors.lastname: Kesic
authors.forename: Nicoletta
authors.initials: N
authors.lastname: Colombo
mesh_terms: D026683:Advisory Committees / Q000331:legislation & jurisprudence; D005060:Europe; D005260:Female; D005298:Fertility / Q000502:physiology; D006176:Gynecology / Q000331:legislation & jurisprudence / Q000379:methods* / Q000458:organization & administration / Q000592:standards; D006801:Humans; D007247:Infertility, Female / Q000209:etiology / Q000517:prevention & control*; D008495:Medical Oncology / Q000331:legislation & jurisprudence / Q000379:methods* / Q000458:organization & administration / Q000592:standards; D009375:Neoplasms, Glandular and Epithelial / Q000150:complications / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000150:complications / Q000628:therapy*